Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:49 PM
Ignite Modification Date:
2025-12-24 @ 6:49 PM
NCT ID:
NCT06017557
Eligibility Criteria:
Inclusion Criteria:
* Patients treated at Fondazione Policlinico Gemelli Hospital, Rome Italy, Trillium -Credit Valley Hospital, Mississauga, Ontario and Princess Margaret Cancer Centre, Toronto, Canada
* Patients fit for cytoreductive surgery
* Patients with a primary diagnosis of suspect Stage III-IV ovarian cancer
* Patients selected for interval cytoreductive surgery after NACT
Exclusion Criteria:
* Patients with pre-operative Stage I-II disease confined to the pelvis
* Patients unfit for surgery
* Lack of information about patients' surgical outcomes and clinicopathological characteristics
* LGSOC, Clear cell and mucinous, non-epithelial histologic subtypes (if available)
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT06017557
Study Brief:
Protocol Section:
NCT06017557